Ligand validation:5IXV

1MZ: 1-METHYLIMIDAZOLE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5IXV_1MZ_A_202	99%	55%	0.048	0.987	0.85	0.73	-	-	2	0	100%	1
5IXV_1MZ_B_502	94%	60%	0.074	0.983	0.87	0.53	-	-	2	0	100%	1
1DUO_1MZ_A_155	93%	20%	0.073	0.973	2.08	1.25	1	2	0	0	100%	1
1AET_1MZ_A_296	85%	25%	0.065	0.935	1.64	1.32	2	1	0	0	100%	1
2H7R_1MZ_A_416	75%	63%	0.093	0.927	0.5	0.75	-	-	2	0	100%	1
4HEZ_1MZ_A_303	64%	50%	0.105	0.904	0.98	0.83	-	-	1	0	100%	0.81
4JO5_1MZ_A_208	15%	29%	0.241	0.817	2.13	0.69	2	-	0	0	100%	0.5

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.